Wafik S. El-Deiry: Passing this bill will help identify effective treatments for cancer
Wafik S. El-Deiry recently shared on LinkedIn:
“Watch the brief video of State of Rhode Island House of Representatives 2024 data sharing bill H7301, its introduction by Deputy Majority Whip of the House Representative Mia Ackerman and my comments on Thursday Feb 15, 2024.
This is an important bill that can help Rhode Island’s law be in line with federal law regarding use of deidentified data that cannot be traced back to individuals. Passing this bill will help Rhode Islanders understand the burden from cancer in the state, help identify effective treatments for cancer and help medical professionals in other specialties here as well.
Source: Wafik S. El-Deiry/LinkedIn
Wafik El-Deiry, MD, PhD, FACP, FRSM, an American Cancer Society Research Professor, is the Associate Dean for Oncologic Sciences at the Warren Alpert Medical School and Director of the Legorreta Cancer Center at Brown University. Dr. El-Deiry discovered p21(WAF1) as a p53 target gene, cell cycle inhibitor, and tumor suppressor that explained the mammalian cell stress response.
This has been the most highly cited original work published in Cell. He discovered TRAIL receptor DR5 as a p53 target, and ONC201/TIC10 as a TRAIL pathway, integrated stress response inducer, and cancer therapeutic with efficacy in diffuse midline glioma and other tumors. He was named one of America’s Top Oncologists by the Consumer Res Council of America in 2008 and 2009. He is a practicing physician-scientist specializing in colorectal cancer treatment.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023